Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Treasury Shares (2022 - 2025)

Kezar Life Sciences (KZR) has disclosed Treasury Shares for 4 consecutive years, with $497.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 95.45% to $497.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $497.0 through Dec 2025, down 95.45% year-over-year, with the annual reading at $497.0 for FY2025, 95.45% down from the prior year.
  • Treasury Shares hit $497.0 in Q4 2025 for Kezar Life Sciences, down from $1127.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $483276.0 in Q1 2023 to a low of $497.0 in Q4 2025.
  • Historically, Treasury Shares has averaged $163972.4 across 4 years, with a median of $41935.0 in 2022.
  • Biggest five-year swings in Treasury Shares: soared 1052.44% in 2023 and later tumbled 96.37% in 2024.
  • Year by year, Treasury Shares stood at $434790.0 in 2022, then tumbled by 94.95% to $21945.0 in 2023, then plummeted by 50.26% to $10916.0 in 2024, then crashed by 95.45% to $497.0 in 2025.
  • Business Quant data shows Treasury Shares for KZR at $497.0 in Q4 2025, $1127.0 in Q3 2025, and $8318.0 in Q2 2025.